Posted by Michael Wonder on 24 Mar 2022
Despite competition, U.S. cancer drug prices rose even as they fell in Germany and Switzerland
24 March 2022 - Even as prices rose substantially in the U.S. over a recent 12 year period, a new analysis found that prices for the same cancer drugs either decreased or did not exceed inflation in Germany or Switzerland, where governments negotiate pricing with manufacturers.
